The SARS-CoV-2 pandemic has changed our lives in many ways. We had to learn new and often difficult ways of maintaining life's fundamental building blocks: family, community, connections, and health. In the face of this, we saw hope emerge through everyday heroes. By harnessing the power of resilience and agility, we quickly adapted and rose to the challenge, to tackle the pandemic. At an unprecedented pace, global and local experts, industry leaders, and researchers developed and launched testing solutions and highly effective vaccines to transform the way we deliver healthcare, all the while maintaining testing and treatment demands for other diseases. The transformation to meet the challenge of COVID-19 does not signify the end, but rather a new beginning.
During these virtual sessions, hear from several experts in the infectious diseases field including Prof. Colm O'Mahony (University of Chester), Prof. Francesco Negro (University Hospitals of Geneva), Prof. José Eduardo Levi (Tropical Medicine Institute, University of São Paulo) and many more. They discuss the newest global and regional trends in infectious diseases, like the challenges posed by emerging pathogens, such as SARS-CoV-2, and well-known threats like Antimicrobial Resistance (AMR).
Discover how access to diagnostics of sexually transmitted diseases, hepatitis and endemic diseases has changed due to the pandemic, how safer transplants can be secured, and what we can expect in the future of infectious diseases diagnostics.
During these virtual sessions, hear from several experts in the infectious diseases field including Prof. Colm O'Mahony (University of Chester), Prof. Francesco Negro (University Hospitals of Geneva), and many more. They discuss the newest global and regional trends in infectious diseases, like the challenges posed by SARS-CoV-2, and how the lessons learnt can help us prepare for the next pandemic.
Discover how access to sexually transmitted diseases diagnostics and congenital infections have changed, how safer transplants can be secured, and what we can expect in the future of infectious diseases diagnostics.
